{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:11Z","timestamp":1760775011588,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007144","name":"University of Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007144","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bmcl.2019.08.023","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:15:25Z","timestamp":1565608525000},"page":"126619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of side arm-modified DOTA scaffolds as multi-site binding ligands for cancer cells over normal cells"],"prefix":"10.1016","volume":"29","author":[{"given":"Vineeta","family":"Rustagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Gomika","family":"Udugamasooriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.08.023_b0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/157016308785739875","article-title":"High-throughput screening assays to discover small-molecule inhibitors of protein interactions","volume":"5","author":"Colas","year":"2008","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0010","first-page":"346","article-title":"The synergy between combinatorial chemistry and high-throughput screening","volume":"11","author":"Diller","year":"2008","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.bmcl.2019.08.023_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpa.2017.03.017","article-title":"Combinatorial chemistry in drug discovery","volume":"38","author":"Liu","year":"2017","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel trends in high-throughput screening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2169\/internalmedicine.42.15","article-title":"Anti-TNFalpha therapy for rheumatoid arthritis: an update","volume":"42","author":"Taylor","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.bmcl.2019.08.023_b0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","article-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","volume":"65","author":"Gerber","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2019.08.023_b0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3949\/ccjm.71.7.551","article-title":"The promise of targeted therapy: cancer drugs become more specific","volume":"71","author":"Segota","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.bmcl.2019.08.023_b0040","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.bbamem.2011.07.026","article-title":"In search of a novel target \u2013 phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy","volume":"1808","author":"Riedl","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2019.08.023_b0045","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1158\/1078-0432.CCR-04-1645","article-title":"Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice","volume":"11","author":"Ran","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2019.08.023_b0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.physiol.65.092101.142459","article-title":"Aminophospholipid asymmetry: a matter of life and death","volume":"65","author":"Balasubramanian","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0055","doi-asserted-by":"crossref","first-page":"30678","DOI":"10.18632\/oncotarget.8929","article-title":"Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1","volume":"7","author":"Desai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2019.08.023_b0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1074\/mcp.R112.026930","article-title":"Glycoprotein disease markers and single protein-omics","volume":"12","author":"Chandler","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.bmcl.2019.08.023_b0065","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1021\/ja201123f","article-title":"On-bead combinatorial synthesis and imaging of chemical exchange saturation transfer magnetic resonance imaging agents to identify factors that influence water exchange","volume":"133","author":"Napolitano","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2019.08.023_b0070","doi-asserted-by":"crossref","first-page":"17904","DOI":"10.1073\/pnas.0906925106","article-title":"High-throughput in vivo screening of targeted molecular imaging agents","volume":"106","author":"Gagnon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bmcl.2019.08.023_b0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/1535-7163.MCT-07-0575","article-title":"In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against alpha4beta1 integrin","volume":"7","author":"Peng","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bmcl.2019.08.023_b0080","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bmcl.2019.08.023_b0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/mrc.4588","article-title":"On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity","volume":"55","author":"Singh","year":"2017","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.bmcl.2019.08.023_b0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/ic00171a018","volume":"23","author":"Spirlet","year":"1984","journal-title":"Inorg Chem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0095","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1039\/c1dt11029b","article-title":"Lanthanide complexes of DOTA monoamide derivatives bearing an isophthalate pendent arm","volume":"40","author":"Shiells","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2019.08.023_b0100","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1021\/ja711193x","article-title":"A peptoid \u201cantibody surrogate\u201d that antagonizes VEGF receptor 2 activity","volume":"130","author":"Udugamasooriya","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2019.08.023_b0105","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1021\/acschembio.5b00592","article-title":"Unbiased selection of peptide-peptoid hybrids specific for lung cancer compared to normal lung epithelial cells","volume":"10","author":"Matharage","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/9780470559277.ch110199","article-title":"On-bead two-color (OBTC) cell screen for direct identification of highly selective cell surface receptor ligands","volume":"4","author":"Udugamasooriya","year":"2012","journal-title":"Curr Protoc Chem Biol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0115","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.tetlet.2012.02.112","article-title":"A cleavable scaffold strategy for the synthesis of one-bead one-compound cyclic peptoid libraries that can be sequenced by tandem mass spectrometry","volume":"53","author":"Simpson","year":"2012","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2019.08.023_b0120","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1039\/C4OB00829D","article-title":"Solid-phase synthesis of peptoid-like oligomers containing diverse diketopiperazine units","volume":"12","author":"Suwal","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0125","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1021\/ol0267578","article-title":"Microwave-assisted solid-phase synthesis of peptoids","volume":"4","author":"Olivos","year":"2002","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2019.08.023_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ab.2009.10.031","article-title":"Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions","volume":"398","author":"De Silva","year":"2010","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0135","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00216-011-5047-7","article-title":"Lanthanide-based time-resolved luminescence immunoassays","volume":"400","author":"Hagan","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.poly.2016.03.039","article-title":"Formation kinetics of europium(III) complexes of DOTA and its bis(phosphonate) bearing analogs","volume":"111","author":"Prochazkova","year":"2016","journal-title":"Polyhedron"},{"key":"10.1016\/j.bmcl.2019.08.023_b0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chembiol.2009.12.015","article-title":"Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries","volume":"17","author":"Astle","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2019.08.023_b0150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acscombsci.5b00090","article-title":"Optimization of the magnetic recovery of hits from one-bead-one-compound library screens","volume":"17","author":"Mendes","year":"2015","journal-title":"ACS Combust Sci"},{"key":"10.1016\/j.bmcl.2019.08.023_b0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.08.023_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.05.040","article-title":"A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1","volume":"137","author":"Shukla","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0360-3016(02)03928-7","article-title":"Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy","volume":"54","author":"Ran","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bmcl.2019.08.023_b0170","first-page":"6132","article-title":"Increased exposure of anionic phospholipids on the surface of tumor blood vessels","volume":"62","author":"Ran","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2019.08.023_b0175","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.bmc.2010.06.086","article-title":"Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates","volume":"18","author":"Nwe","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.08.023_b0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cplu.201300096","article-title":"In vivo magnetic resonance imaging detection of paramagnetic liposomes loaded with amphiphilic gadolinium(III) complexes: impact of molecular structure on relaxivity and excretion efficiency","volume":"78","author":"Cittadino","year":"2013","journal-title":"ChemPlusChem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19305505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19305505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:30:42Z","timestamp":1760772642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19305505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":36,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0960894X19305505"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.08.023","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of side arm-modified DOTA scaffolds as multi-site binding ligands for cancer cells over normal cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126619"}}